Publication | Closed Access
Lenalidomide in combination with an activin A-neutralizing antibody: preclinical rationale for a novel anti-myeloma strategy
43
Citations
33
References
2013
Year
Hematological MalignancyMedicineMalignant Blood DisorderImmunologyHematologyAutoimmunityImmunotherapyPharmacologyActivin A-neutralizing AntibodyNovel Anti-myeloma StrategyPreclinical RationaleMyeloid Neoplasia
| Year | Citations | |
|---|---|---|
Page 1
Page 1